Mercy Expands AI-Driven Smart-Texting Program for Chemotherapy Patients

Mercy has been awarded a four-year funding grant from the Patient-Centered Outcomes Research Institute (PCORI) to expand its AI-driven smart-texting program. This initiative, announced in a press release, will extend the program's reach to all chemotherapy patients aged 18 and older, enhancing the existing electronic patient-reported monitoring platform.
The expansion will not only broaden the age group but also include additional health areas such as physical function, behavioral health, and health-related social needs. The program will also incorporate automated phone systems and MyMercy messages for patients who do not respond to text messages.
The project builds on findings from a PCORI-funded study that demonstrated improved symptom control and quality of life for patients using electronic patient-reported outcome surveys. The expanded program is expected to be available to patients by October 2026.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Funding
More from: Life Sciences
Subscribe to AI Funding Brief
Market report
2025 Generative AI in Professional Services Report
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read more